Hochhaus et al. Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Blood. 2008;111:1039-1043.

On pages1039 and 1043 in the February 1, 2008, issue, the eighth author's last name, affiliation, and contributing author initials are incorrect. The correct name is Carlo Gambacorti-Passerini; the affiliation is S. Gerardo Hospital, University of Milano Bicocca, Monza, Italy; and the correct author initials in the Contribution paragraph of “Authorship” are C.G.-P. The errors were corrected in the online version, which now differs from the print version.